Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
10 Years Aggregate
CFO
$-145.62 Mln
EBITDA
$-183.77 Mln
Net Profit
$-176.64 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fresh Tracks Therapeutics Inc (FRTX)
| -- | -- | -- | 3.8 | -- | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
Company
|
2023
|
|---|---|
|
Fresh Tracks Therapeutics Inc (FRTX)
| -41.3 |
|
BSE Sensex
| 18.7 |
|
BSE Sensex
| 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Fresh Tracks Therapeutics Inc (FRTX)
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the... United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado. Read more
-
CEO, CFO, Secretary & Chairman
Mr. Albert Nicholas Marchio II
-
CEO, CFO, Secretary & Chairman
Mr. Albert Nicholas Marchio II
-
Headquarters
Boulder, CO
-
Website
FAQs for Fresh Tracks Therapeutics Inc (FRTX)
What is the current share price of Fresh Tracks Therapeutics Inc (FRTX) Today?
The share price of Fresh Tracks Therapeutics Inc (FRTX) is $0.94 (NASDAQ) as of 28-Feb-2025 12:19 EDT. Fresh Tracks Therapeutics Inc (FRTX) has given a return of 3.77% in the last 1 years.
What is the current PB & PE ratio of Fresh Tracks Therapeutics Inc (FRTX)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-0.91 |
0.52 |
2022 |
-0.22 |
0.63 |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of Fresh Tracks Therapeutics Inc (FRTX)?
The 52-week high and low of Fresh Tracks Therapeutics Inc (FRTX) are Rs -- and Rs -- as of 06-Sep-2026.
What is the market cap of Fresh Tracks Therapeutics Inc (FRTX)?
Fresh Tracks Therapeutics Inc (FRTX) has a market capitalisation of $ 6 Mln as on 28-Feb-2025. As per SEBI classification, it is a company.
Should I invest in Fresh Tracks Therapeutics Inc (FRTX)?
Before investing in Fresh Tracks Therapeutics Inc (FRTX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.